These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24094113)

  • 1. MiR-34a is up-regulated in response to low dose, low energy X-ray induced DNA damage in breast cells.
    Stankevicins L; Almeida da Silva AP; Ventura Dos Passos F; Dos Santos Ferreira E; Menks Ribeiro MC; G David M; J Pires E; Ferreira-Machado SC; Vassetzky Y; de Almeida CE; de Moura Gallo CV
    Radiat Oncol; 2013 Oct; 8():231. PubMed ID: 24094113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-155, miR-21, and let-7a Expressions in MCF-10A and MCF-7 Cell Lines after Low to High Dose Irradiation.
    Zare A; Fardid R; Tamadon GHH; Mosleh-Shirazi MA
    Cell J; 2021 Oct; 23(5):532-537. PubMed ID: 34837680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression level of miR-34a rather than P53 gene status correlates with mutability in related human lymphoblast cell lines.
    Chen X; Yan J; Chen T
    Mol Carcinog; 2012 Aug; 51(8):674-7. PubMed ID: 21809390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-34a as part of the resistance network in chronic lymphocytic leukemia.
    Zenz T; Mohr J; Eldering E; Kater AP; Bühler A; Kienle D; Winkler D; Dürig J; van Oers MH; Mertens D; Döhner H; Stilgenbauer S
    Blood; 2009 Apr; 113(16):3801-8. PubMed ID: 18941118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic effects of valproic acid on miR-34a, miR-520h and HDAC1 gene in breast cancer.
    Injinari N; Amini-Farsani Z; Yadollahi-Farsani M; Teimori H
    Life Sci; 2021 Mar; 269():119027. PubMed ID: 33453248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis.
    Javeri A; Ghaffarpour M; Taha MF; Houshmand M
    Med Oncol; 2013 Mar; 30(1):413. PubMed ID: 23292869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
    Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
    Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
    Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
    Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of miR-34a Effect on CCND1 mRNA Level and Sensitization of Breast Cancer Cell Lines to Paclitaxel.
    Irani S; Paknejad M; Soleimani M; Azam S
    Iran Biomed J; 2020 Nov; 24(6):361-9. PubMed ID: 32660221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could miR-34a Inhibition be Used as a Tool to Overcome Drug Resistance in MCF-7 Cells Treated with Synthesized Steroidal Heterocycles?
    Yahya SMM; Abd-Elhalim MM; Abdelhamid AO; Eskander EF; Elsayed GH
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):819-826. PubMed ID: 33773546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [miR-34a may regulate sensitivity of breast cancer cells to adriamycin via targeting Notch1].
    Li X; Zhao J; Tang J
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):892-6. PubMed ID: 25623761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells.
    Hargraves KG; He L; Firestone GL
    Mol Carcinog; 2016 May; 55(5):486-98. PubMed ID: 25789847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro RNA 34a and Let-7a Expression in Human Breast Cancers is Associated with Apoptotic Expression Genes.
    Mansoori B; Mohammadi A; Shirjang S; Baghbani E; Baradaran B
    Asian Pac J Cancer Prev; 2016; 17(4):1887-90. PubMed ID: 27221871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological effects induced by doses of mammographic screening.
    Pereira L; Ferreira MT; Lima AGF; Salata C; Ferreira-Machado SC; Lima I; Morandi V; Magalhães LAG
    Phys Med; 2021 Jul; 87():90-98. PubMed ID: 34130221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The secretome of non-tumorigenic mammary cells MCF-10A elicits DNA damage in MCF-7 and MDA-MB-231 breast cancer cells.
    Vedoya GM; López Nigro MM; Martín GA
    Toxicol In Vitro; 2021 Feb; 70():105018. PubMed ID: 33049311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells.
    Anastasov N; Höfig I; Vasconcellos IG; Rappl K; Braselmann H; Ludyga N; Auer G; Aubele M; Atkinson MJ
    Radiat Oncol; 2012 Dec; 7():206. PubMed ID: 23216894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background.
    Ye Z; Fang J; Dai S; Wang Y; Fu Z; Feng W; Wei Q; Huang P
    Cancer Lett; 2016 Jan; 370(2):216-21. PubMed ID: 26523671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.